Inhibikase Therapeutics Stock Technical Analysis
| IKT Stock | USD 2.72 0.04 1.45% |
As of the 18th of January 2025, Inhibikase Therapeutics retains the Market Risk Adjusted Performance of (1.66), risk adjusted performance of 0.1316, and Downside Deviation of 6.86. Inhibikase Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Inhibikase Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Inhibikase, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InhibikaseInhibikase |
Inhibikase Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 7.0 | Strong Buy | 3 | Odds |
Most Inhibikase analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Inhibikase stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Inhibikase Therapeutics, talking to its executives and customers, or listening to Inhibikase conference calls.
Inhibikase Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Inhibikase Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Inhibikase Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Inhibikase Therapeutics Trend Analysis
Use this graph to draw trend lines for Inhibikase Therapeutics. You can use it to identify possible trend reversals for Inhibikase Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Inhibikase Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Inhibikase Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Inhibikase Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.01 , which may imply that Inhibikase Therapeutics will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 5.94, which is the sum of squared deviations for the predicted Inhibikase Therapeutics price change compared to its average price change.About Inhibikase Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Inhibikase Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Inhibikase Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Inhibikase Therapeutics price pattern first instead of the macroeconomic environment surrounding Inhibikase Therapeutics. By analyzing Inhibikase Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Inhibikase Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Inhibikase Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2024 | 2025 (projected) | Payables Turnover | 0.00584 | 18.95 | 19.9 | Days Of Inventory On Hand | 60.7K | 54.6K | 57.3K |
Inhibikase Therapeutics January 18, 2025 Technical Indicators
Most technical analysis of Inhibikase help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Inhibikase from various momentum indicators to cycle indicators. When you analyze Inhibikase charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1316 | |||
| Market Risk Adjusted Performance | (1.66) | |||
| Mean Deviation | 5.05 | |||
| Semi Deviation | 5.88 | |||
| Downside Deviation | 6.86 | |||
| Coefficient Of Variation | 680.76 | |||
| Standard Deviation | 7.31 | |||
| Variance | 53.37 | |||
| Information Ratio | 0.1428 | |||
| Jensen Alpha | 1.08 | |||
| Total Risk Alpha | 0.891 | |||
| Sortino Ratio | 0.1522 | |||
| Treynor Ratio | (1.67) | |||
| Maximum Drawdown | 37.4 | |||
| Value At Risk | (9.83) | |||
| Potential Upside | 15.17 | |||
| Downside Variance | 47.01 | |||
| Semi Variance | 34.57 | |||
| Expected Short fall | (5.66) | |||
| Skewness | 0.483 | |||
| Kurtosis | 1.05 |
Additional Tools for Inhibikase Stock Analysis
When running Inhibikase Therapeutics' price analysis, check to measure Inhibikase Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibikase Therapeutics is operating at the current time. Most of Inhibikase Therapeutics' value examination focuses on studying past and present price action to predict the probability of Inhibikase Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibikase Therapeutics' price. Additionally, you may evaluate how the addition of Inhibikase Therapeutics to your portfolios can decrease your overall portfolio volatility.